Long term follow-up of Thalidomide plus Interleukin-2 based therapy in metastatic renal cell cancer patients
نویسندگان
چکیده
__________________________________________________________________________________ *Correspondence: Robert J Amato, DO, Professor, University of Texas Medical School, Department of Internal Medicine, Division of Oncology, 6410 Fannin, Suite 710, Houston, Texas 77030, USA; Tel: 832-325-7701; Fax; 713-512-7132; e-mail: [email protected]
منابع مشابه
Long term follow up of recurrent uterine cervical cancer: A Case Report
Background and Aim: Carcinoma of the uterine cervix is a significant cause of mortality because of malignancy in women. Radiotherapy is a major treatment modality for invasive cervical cancer with good treatment outcome in early-stage patients. However, substantial treatment failures still occur in the advanced-stage patients. In this case report a long term follow up of a 58 years old woman wi...
متن کاملLong-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatment.
PURPOSE Medical Research Council (MRC) Myeloma IX was a phase III trial evaluating bisphosphonate and thalidomide-based therapy for newly diagnosed multiple myeloma. Results were reported previously after a median follow-up of 3.7 years (current controlled trials number: ISRCTN68454111). Survival outcomes were reanalyzed after an extended follow-up (median, 5.9 years). EXPERIMENTAL DESIGN At ...
متن کاملLong-term outcome of transfemoral thrombectomy in patients with acute iliofemoral vein thrombosis
Abstract Background: The optimal therapy of acute iliofemoral venous thrombosis is still a matter of debate. The purpose of our study was to evaluate the late results of iliofemoral thrombectomy with regard to the prevention of the development of a Post Thrombotic Syndrome (PTS). Methods: During 2000-2003, 18 patients underwent transfemoral venous thrombectomy for acute iliofemoral venous thro...
متن کاملبدخیـــمی بعد از پیــوند کلیــه
Background: Long term use of immunosuppressive therapy in transplant recipients in order to prevent acute and chronic rejection increases the long term risk of cancer. This study evaluates the incidence of different organs’ cancer after renal transplantation and immunosuppressive therapy. Methods: This is a retrospective analysis of malignant tumors in renal graft recipients with more than...
متن کاملWhich complaint has the most clinical effect on quality of life of thyroid cancer survivors in long term follow up?
Introduction: Differentiated thyroid cancer (DTC) is the most common endocrine malignancy. This malignancy generally has an excellent prognosis with more than 90% long term survival. Consequently, life quality improvement is the first priority especially in the young DTC survivors. In classic management of a new DTC patient, each therapeutic modality can significantly induce morbidities. In the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009